What is it about?
Please see my explainer for version 2 of this article, which updates the scientific content in some important ways in response to valuable comments by reviewer Dr. Natalja Strelkova. There is, incidentally, also a version 3 of this article, which was produce for purely technical reasons to correct information on the licensing page. https://www.growkudos.com/publications/10.12688%25252Ff1000research.10624.2/author
Featured Image
Read the Original
This page is a summary of: Dose Titration Algorithm Tuning (DTAT) should supersede the Maximum Tolerated Dose (MTD) concept in oncology dose-finding trials, F1000Research, February 2017, Faculty of 1000, Ltd.,
DOI: 10.12688/f1000research.10624.1.
You can read the full text:
Contributors
The following have contributed to this page